SPONSOR
Amgen
Total Trials
7
Recruiting
7
Phases
Phase 3, Phase 2, Phase 1
Conditions studied: Secondary HyperparathyroidismMajor Cardiovascular EventEstablished Atherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular DiseaseOverweightObesityAdvanced Solid TumorsMetastatic Castration-resistant Prostate CancerCardiometabolic DiseaseCardiovascular Disease
Amgen is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Secondary Hyperparathyroidism, Major Cardiovascular Event, Established Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease.
The trial portfolio spans Phase 3, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Amgen
How many clinical trials has Amgen sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Amgen, of which 7 are actively recruiting participants. These trials cover conditions including Secondary Hyperparathyroidism, Major Cardiovascular Event, Established Atherosclerotic Cardiovascular Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Amgen research focus on?
Amgen clinical trials span Secondary Hyperparathyroidism, Major Cardiovascular Event, Established Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease, Overweight, and additional conditions. The research pipeline includes Phase 3, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Amgen clinical trial?
To participate in a Amgen trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Amgen trials with current recruitment status updated daily.
Clinical Trials by Amgen
NCT03969329 Phase 3
Recruiting
A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
Secondary Hyperparathyroidism
NCT06295679
Recruiting
A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease
Major Cardiovascular Event
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease
NCT07172919 Phase 2
Recruiting
A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
Advanced Solid Tumors
NCT07213674 Phase 3
Recruiting
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
NCT06585462 Phase 1
Recruiting
Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity
Cardiometabolic Disease
NCT07293260 Phase 3
Recruiting
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
Cardiovascular Disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology